Aaberge IS - Search Results

1

Immunogenicity and safety of a combination of two serogroup B meningococcal outer membrane vesicle vaccines.

Sandbu S, Feiring B, Oster P, Helland OS, Bakke HS, Naess LM, Aase A, Aaberge IS, Kristoffersen AC, Rydland KM, Tilman S, Nøkleby H, Rosenqvist E. Sandbu S, et al. Among authors: aaberge is. Clin Vaccine Immunol. 2007 Sep;14(9):1062-9. doi: 10.1128/CVI.00094-07. Epub 2007 Jul 18. Clin Vaccine Immunol. 2007. PMID: 17634513 Free PMC article. Clinical Trial.

2

Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control.

Thornton V, Lennon D, Rasanathan K, O'Hallahan J, Oster P, Stewart J, Tilman S, Aaberge I, Feiring B, Nokleby H, Rosenqvist E, White K, Reid S, Mulholland K, Wakefield MJ, Martin D. Thornton V, et al. Vaccine. 2006 Feb 27;24(9):1395-400. doi: 10.1016/j.vaccine.2005.09.043. Epub 2005 Oct 4. Vaccine. 2006. PMID: 16242221 Clinical Trial.

3

Immunisation schedules for non-replicating nasal vaccines can be made simple by allowing time for development of immunological memory.

Bakke H, Setek TN, Huynh PN, Haugen IL, Høiby EA, Holst J, Aaberge IS, Haneberg B. Bakke H, et al. Among authors: aaberge is. Vaccine. 2004 Jun 2;22(17-18):2278-84. doi: 10.1016/j.vaccine.2003.11.040. Vaccine. 2004. PMID: 15149787

4

The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease.

Holst J, Feiring B, Naess LM, Norheim G, Kristiansen P, Høiby EA, Bryn K, Oster P, Costantino P, Taha MK, Alonso JM, Caugant DA, Wedege E, Aaberge IS, Rappuoli R, Rosenqvist E. Holst J, et al. Among authors: aaberge is. Vaccine. 2005 Mar 18;23(17-18):2202-5. doi: 10.1016/j.vaccine.2005.01.058. Vaccine. 2005. PMID: 15755595

5

Combined administration of meningococcal serogroup B outer membrane vesicle vaccine and conjugated serogroup C vaccine indicated for prevention of meningococcal disease is safe and immunogenic.

Aaberge IS, Oster P, Helland OS, Kristoffersen AC, Ypma E, Høiby EA, Feiring B, Nøkleby H. Aaberge IS, et al. Clin Diagn Lab Immunol. 2005 May;12(5):599-605. doi: 10.1128/CDLI.12.5.599-605.2005. Clin Diagn Lab Immunol. 2005. PMID: 15879021 Free PMC article.

6

Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccine.

Feiring B, Fuglesang J, Oster P, Naess LM, Helland OS, Tilman S, Rosenqvist E, Bergsaker MA, Nøkleby H, Aaberge IS. Feiring B, et al. Among authors: aaberge is. Clin Vaccine Immunol. 2006 Jul;13(7):790-6. doi: 10.1128/CVI.00047-06. Clin Vaccine Immunol. 2006. PMID: 16829617 Free PMC article. Clinical Trial.

7

Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity.

Aase A, Herstad TK, Merino S, Bolstad M, Sandbu S, Bakke H, Aaberge IS. Aase A, et al. Among authors: aaberge is. Clin Vaccine Immunol. 2011 Aug;18(8):1269-74. doi: 10.1128/CVI.05067-11. Epub 2011 Jun 15. Clin Vaccine Immunol. 2011. PMID: 21677109 Free PMC article.

8

Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future.

Holst J, Oster P, Arnold R, Tatley MV, Næss LM, Aaberge IS, Galloway Y, McNicholas A, O'Hallahan J, Rosenqvist E, Black S. Holst J, et al. Among authors: aaberge is. Hum Vaccin Immunother. 2013 Jun;9(6):1241-53. doi: 10.4161/hv.24129. Epub 2013 Mar 7. Hum Vaccin Immunother. 2013. PMID: 23857274 Free PMC article. Review.

9

Meningococcal outer membrane vesicle vaccine given intranasally can induce immunological memory and booster responses without evidence of tolerance.

Bakke H, Lie K, Haugen IL, Korsvold GE, Høiby EA, Naess LM, Holst J, Aaberge IS, Oftung F, Haneberg B. Bakke H, et al. Among authors: aaberge is. Infect Immun. 2001 Aug;69(8):5010-5. doi: 10.1128/IAI.69.8.5010-5015.2001. Infect Immun. 2001. PMID: 11447180 Free PMC article.

10

Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease.

Holst J, Feiring B, Fuglesang JE, Høiby EA, Nøkleby H, Aaberge IS, Rosenqvist E. Holst J, et al. Among authors: aaberge is. Vaccine. 2003 Jan 30;21(7-8):734-7. doi: 10.1016/s0264-410x(02)00591-1. Vaccine. 2003. PMID: 12531351 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page